NanoSyrinx appoints Anthony Johnson as Non-Executive Director

COVENTRY, United Kingdom--(BUSINESS WIRE)--NanoSyrinx, a synthetic biology company developing a novel platform for targeted intracellular delivery of biologic therapeutics, today announced Anthony Johnson, M. D., has joined its Board as Non-Executive Director. Tony’s appointment forms part of the Company’s ongoing strategy to expand and strengthen its leadership team as the Company prepares for the next stage in its development. Most recently, Tony held the position of Chief Executive Officer a